2. 您的位置
3. 首页
4. 会议论文
5. Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury

Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury

来源 :中国免疫学会第十届全国免疫学学术大会 | 被引量 : 0次 | 上传用户：xiuluoyanyu1986

【摘 要】

：

Since 2013, the emergence of an avian-origin influenza A (H7N9) virus has raised concern in China.Although most infections resulted in respiratory illness, some severe cases resulted in acute respirat

【作 者】

：

Penghui Yang Hongjing Gu Chengcai Lai Shaogeng Zhang Xiliang Wang 

【机 构】

：

Beijing 302 Hospital;State Key Laboratory of Pathogens and Biosecurity,Beijing Institute of Microbio

【出 处】

：

中国免疫学会第十届全国免疫学学术大会

【发表日期】

：

2015年10期

【关键词】

：

H7N9 influenza ACE2 lung injury 

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　Since 2013, the emergence of an avian-origin influenza A (H7N9) virus has raised concern in China.Although most infections resulted in respiratory illness, some severe cases resulted in acute respiratory distress syndrome (ARDS), which is a severe form of acute lung injury (ALI) that further contributes to morbidity.

其他文献

Comparison of cellular and humoral immunity between Influenza A/H1N1/2009 infected patients and vacc

Aim: The epidemic Influenza A/H1N1 in 2009 causes severe morbidity and mortality mainly in elder and children population.

会议

Pandemic A/H1N1 Influenzamonovalent A/H1N1 influenza vaccinehumoral immunityc

单剂水凝胶他克奠司促进大鼠肝移植长期存活

背景：肝移植是目前治疗终末期肝病最有效的治疗方式，近年来随着外科学、影像学尤其是免疫抑制剂的应用，移植受者生存率获得了显著提高。但长期的免疫抑制剂如他克莫司(FK506)的应用会带来许多严重的副作用如感染、肾毒性、代谢紊乱等。

会议

肝移植免疫抑制剂他克莫司

NKp30+ NK cells contribute to HBV control during Pegylated-interferon-alfa-2b therapy of chronic hep

Approximately 400 million people are chronic HBV surface antigen carriers.There is a pressing need to improve therapeutic options for chronic hepatitis B.Pegylated interferon alpha (Peg-IFN-α) achieve

会议

HBeAg-positive CHBDynamicallyImmunomodulatoryIL-15NKG2A

The polarization of macrophage in the course of Mycobacterium tuberculosis infection and it's r

Background: Macrophages, the nucleating cells and predominant constituent members of tuberculous granuloma, play key roles in the formation and development of tuberculous granuloma.

会议

Tuberculosis granulomaMacrophagePolarization

Pegylated Interferon-α Followed by low-dose Interleukin-2 improves the anti-HBV Immunity for HBV non

Background: More than 60% of patients infected with hepatitis B virus (HBV) regarded as NR have a diminished HBV virologic response to standard interferon (IFN)-based therapies.

会议

hepatitis B virus (HBV)Interleukin (IL)-2non-responderseffector cytokinesTre

HLA-A2限制的汉滩病毒核蛋白CD8+T细胞表位在转基因小鼠体内的免疫保护作用研究

背景：汉滩病毒(HTNV)是引起我国肾综合征出血热(HFRS)的主要病原体.前期研究我们鉴定出HLA-A2限制的HTNV核蛋白(NP) CD8+T细胞表位FVVPILLKA (FA-9,aa131-aa139),发现其特异性应答水平与患者病情成负相关,提示其有免疫保护作用.但该表位在体内诱导特异性抗病毒应答的能力尚未研究.目的：研究HLA-A2限制的FA-9表位特异性CTL应答在HLA-A2.1/

会议

汉滩病毒表位HLA-A2.1/Kb转基因小鼠CD8+T细胞应答

Aptamer against ManLAM promotes M1 macrophage and Th1 cell polarization and enhances immunogenicity

Introduction: Currently Tuberculosis (TB) is still a serious public health challenge that contributes significantly to illness and death around the world.

会议

BCGManLAMaptamersimmunoadjuvantM1macrophageTh1 cell polarization

Tim-3 negatively regulates the NLRP3 inflammasome and protects against peritonitis

BACKGROUND&Aims: The NLRP3 inflammasome is a cytosolic multi-protein complex and assembled in response to both DAMP and PAMP.

会议

Tim-3NLRP3 inflammasomemacrophageperitonitis

Epigenetic regulation of IL-12/IL-23 gene expression and autoimmune responses by deubiquitinase Trab

Aims: The proinflammatory cytokines IL-12 and IL-23 connect innate immunity to adaptive immune responses and are also involved in autoimmune and inflammatory diseases.

会议

TrabidUbiquitinationIL-12Jmjd2dEAE

Raf kinase inhibitor protein and TANK-binding kinase 1 form a positive feedback loop to promote type

TANK-binding kinase 1 (TBK1) activation is a central event in type I interferon production in anti-virus innate immunity.However, the regulatory mechanism underlying TBK1 activation remains unclear.

会议

TBK1RKIPtype Ⅰ interferonantiviral immunity